<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewalPatrick Killela, Hai Yan, Zachary J. Reitman et al.|Proceedings of the National Academy of Sciences|2013Cited by 1.4k
Aristolochic acid and the etiology of endemic (Balkan) nephropathyArthur P. Grollman, Bojan Jelaković, Shinya Shibutani et al.|Proceedings of the National Academy of Sciences|2007Cited by 598
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)Francesco Soria, George N. Thalmann, Marko Babjuk et al.|World Journal of Urology|2016Cited by 471
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acidBojan Jelaković, Kathleen G. Dickman, Sandra Karanović et al.|Kidney International|2011Cited by 213
<i>TP</i>53 Mutational signature for aristolochic acid: an environmental carcinogenMasaaki Moriya, Arthur P. Grollman, Neda Slade et al.|International Journal of Cancer|2011Cited by 107